Current status and perspectives in stem cell therapy for heart

Fen Chiung Lin, Wen Pin Chen, Pao Hsien Chu, Kou Gi Shyu, Ming Shien Wen

Research output: Contribution to journalReview article

Abstract

Formost patients, the prognosis of heart failure remains poor despite therapeutic advancement in recent decades. The option of cardiac transplantation is high risk and limited by a shortage of donors. Traditionally, the heart had been considered a terminally differentiated organ incapable of regeneration. However, numerous preclinical and clinical studies have been performed since the first report of cell therapy in heart failure using skeletalmyoblasts in 2001. These investigations looked at the promising potential and use of several kinds of stem cells, which could some day dramatically alter the understanding of the regenerative capacity of the heart. To date, although there is no existing cardiac cell therapy that has been conclusively reported to be effective, stem cell-related cardiomyocyte regeneration strategies have become significant areas of research in modern cardiovascular medicine. In this review,we outline a variety of common cell sources, surface biomarkers of stem cells, and provide information related to cardiac cell therapy clinical trials.

Original languageEnglish
Pages (from-to)382-394
Number of pages13
JournalActa Cardiologica Sinica
Volume30
Issue number5
Publication statusPublished - Sep 1 2014

Fingerprint

Cell- and Tissue-Based Therapy
Stem Cells
Regeneration
Heart Failure
Modern 1601-history
Heart Transplantation
Cardiac Myocytes
Biomarkers
Tissue Donors
Clinical Trials
Research
Therapeutics

Keywords

  • Clinical trial
  • Stem cell

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Lin, F. C., Chen, W. P., Chu, P. H., Shyu, K. G., & Wen, M. S. (2014). Current status and perspectives in stem cell therapy for heart. Acta Cardiologica Sinica, 30(5), 382-394.

Current status and perspectives in stem cell therapy for heart. / Lin, Fen Chiung; Chen, Wen Pin; Chu, Pao Hsien; Shyu, Kou Gi; Wen, Ming Shien.

In: Acta Cardiologica Sinica, Vol. 30, No. 5, 01.09.2014, p. 382-394.

Research output: Contribution to journalReview article

Lin, FC, Chen, WP, Chu, PH, Shyu, KG & Wen, MS 2014, 'Current status and perspectives in stem cell therapy for heart', Acta Cardiologica Sinica, vol. 30, no. 5, pp. 382-394.
Lin FC, Chen WP, Chu PH, Shyu KG, Wen MS. Current status and perspectives in stem cell therapy for heart. Acta Cardiologica Sinica. 2014 Sep 1;30(5):382-394.
Lin, Fen Chiung ; Chen, Wen Pin ; Chu, Pao Hsien ; Shyu, Kou Gi ; Wen, Ming Shien. / Current status and perspectives in stem cell therapy for heart. In: Acta Cardiologica Sinica. 2014 ; Vol. 30, No. 5. pp. 382-394.
@article{7b9a009c324249c497b87d87fd6bada7,
title = "Current status and perspectives in stem cell therapy for heart",
abstract = "Formost patients, the prognosis of heart failure remains poor despite therapeutic advancement in recent decades. The option of cardiac transplantation is high risk and limited by a shortage of donors. Traditionally, the heart had been considered a terminally differentiated organ incapable of regeneration. However, numerous preclinical and clinical studies have been performed since the first report of cell therapy in heart failure using skeletalmyoblasts in 2001. These investigations looked at the promising potential and use of several kinds of stem cells, which could some day dramatically alter the understanding of the regenerative capacity of the heart. To date, although there is no existing cardiac cell therapy that has been conclusively reported to be effective, stem cell-related cardiomyocyte regeneration strategies have become significant areas of research in modern cardiovascular medicine. In this review,we outline a variety of common cell sources, surface biomarkers of stem cells, and provide information related to cardiac cell therapy clinical trials.",
keywords = "Clinical trial, Stem cell",
author = "Lin, {Fen Chiung} and Chen, {Wen Pin} and Chu, {Pao Hsien} and Shyu, {Kou Gi} and Wen, {Ming Shien}",
year = "2014",
month = "9",
day = "1",
language = "English",
volume = "30",
pages = "382--394",
journal = "Acta Cardiologica Sinica",
issn = "1011-6842",
publisher = "Republic of China Society of Cardiology",
number = "5",

}

TY - JOUR

T1 - Current status and perspectives in stem cell therapy for heart

AU - Lin, Fen Chiung

AU - Chen, Wen Pin

AU - Chu, Pao Hsien

AU - Shyu, Kou Gi

AU - Wen, Ming Shien

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Formost patients, the prognosis of heart failure remains poor despite therapeutic advancement in recent decades. The option of cardiac transplantation is high risk and limited by a shortage of donors. Traditionally, the heart had been considered a terminally differentiated organ incapable of regeneration. However, numerous preclinical and clinical studies have been performed since the first report of cell therapy in heart failure using skeletalmyoblasts in 2001. These investigations looked at the promising potential and use of several kinds of stem cells, which could some day dramatically alter the understanding of the regenerative capacity of the heart. To date, although there is no existing cardiac cell therapy that has been conclusively reported to be effective, stem cell-related cardiomyocyte regeneration strategies have become significant areas of research in modern cardiovascular medicine. In this review,we outline a variety of common cell sources, surface biomarkers of stem cells, and provide information related to cardiac cell therapy clinical trials.

AB - Formost patients, the prognosis of heart failure remains poor despite therapeutic advancement in recent decades. The option of cardiac transplantation is high risk and limited by a shortage of donors. Traditionally, the heart had been considered a terminally differentiated organ incapable of regeneration. However, numerous preclinical and clinical studies have been performed since the first report of cell therapy in heart failure using skeletalmyoblasts in 2001. These investigations looked at the promising potential and use of several kinds of stem cells, which could some day dramatically alter the understanding of the regenerative capacity of the heart. To date, although there is no existing cardiac cell therapy that has been conclusively reported to be effective, stem cell-related cardiomyocyte regeneration strategies have become significant areas of research in modern cardiovascular medicine. In this review,we outline a variety of common cell sources, surface biomarkers of stem cells, and provide information related to cardiac cell therapy clinical trials.

KW - Clinical trial

KW - Stem cell

UR - http://www.scopus.com/inward/record.url?scp=84907272091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907272091&partnerID=8YFLogxK

M3 - Review article

VL - 30

SP - 382

EP - 394

JO - Acta Cardiologica Sinica

JF - Acta Cardiologica Sinica

SN - 1011-6842

IS - 5

ER -